ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,991Medicare Part D Prescriptions Filled, Including Refills

Rank: 208 out of 2604

$533K Total Retail Price of All Prescriptions

Rank: 169 out of 2604

368 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 368 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 6,268 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 369 291 1 2
HYDROCODONE-ACETAMINOPHEN 270 192 S3 2 1
LISINOPRIL 266 208 3 3
AMLODIPINE BESYLATE 256 223 4 6
OMEPRAZOLE 239 162 5 5
TRAMADOL HCL 221 183 6 15
LEVOTHYROXINE SODIUM 204 184 7 4
HYDROCHLOROTHIAZIDE 189 166 8 10
WARFARIN SODIUM 189 172 8 13
METOPROLOL TARTRATE 153 138 10 9
PRAVASTATIN SODIUM 152 136 11 14
FUROSEMIDE 146 125 12 8
LOVASTATIN 142 116 13 24
METFORMIN HCL 129 75 14 7
LOSARTAN POTASSIUM 115 106 15 20
ATENOLOL 107 78 16 11
METFORMIN HCL ER 104 82 17 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 78 18 22
METOPROLOL SUCCINATE 97 86 19 17
AZITHROMYCIN 91 77 20 33
ALENDRONATE SODIUM 90 51 21 29
POTASSIUM CHLORIDE 83 77 22 16
SERTRALINE HCL 81 59 23 23
METHYLPREDNISOLONE 77 70 24 112
GLIMEPIRIDE 74 61 25 57
TAMSULOSIN HCL 74 64 25 30
ALLOPURINOL 72 52 27 35
TRIAMTERENE-HCTZ 70 54 28 55
LANTUS 68 64 29 40
INSULIN SYRINGE 67 56 30 109
LANTUS SOLOSTAR 66 38 31 84
GABAPENTIN 64 37 32 12
BENAZEPRIL HCL 63 56 33 139
PEN NEEDLE 62 49 34 145
ISOSORBIDE MONONITRATE ER 61 57 35 38
ATORVASTATIN CALCIUM 60 43 36 19
KLOR-CON 10 58 58 37 173
BUMETANIDE 53 50 38 70
PLAVIX 51 40 39 75
CARVEDILOL 50 46 40 26
LANSOPRAZOLE 50 36 40 137
CITALOPRAM HBR 50 37 40 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.